June 25th, 2019 | Lille
IMODE is organising its third annual convention during MedFIT with a morning conference on June 25th. IMODE will also hold a stand during MedFIT convention and participate to MedFIT one-to-one meetings.
PROGRAMME | June 25th
8.30 – 9.00 AM
Name badge pickup and Welcome coffee – MedFIT
9.00 AM – 09.30 AM
Pr. Dennis Douroumis, University of Greenwich, Faculty of Engineering and Science.
3D-printing of bioabsorbable drug eluting stents for the treatment of coronary artery diseases – The magic disappearing stents
09.30 AM – 10.00 AM
Dr. Michael Okereke, University of Greenwich, Faculty of Engineering and Science.
Development of a Virtual Testing Platform for analysis of in vivo response of 3D printed coronary artery stents.
10.00 AM – 10.30 AM
MD Justine Mougin, University of Lille, UMET Laboratory
10.30 AM – 11.00 AM
Networking break – MedFIT
11.00 AM – 11.30 AM
Dr Sheng Qi, University of East Anglia.
Translating Drug-Eluting Contact Lenses from Bench to Practice: Promises and Obstacles
11.30 AM – 12.00 AM
Pr. Sharma Pankaj, Ashford and St Peter’s Hospital’s NHS Foundation Trust
Genetics of strokes
12.00 AM – 12.30 AM
Satinder Faulkner, UK.
I am not afraid of storms for I am learning to sail my ship
12.30 AM – 2.00 PM
Lunch – MedFIT
1.00 PM – 6.00 PM
Access to MedFIT and one-to-one meetings
- Registration to IMODE convention is free but mandatory, it gives you a free access for the afternoon of the 25th of June to MedFIT.
- By participating to IMODE convention, you may obtain a 50% discount on your MedFIT pass for the second day, the 26th of June.
IMODE is a collaborative research project for multicomponent pharmaceutical products (co-amorphous and co-crystals) and medical devices that are loaded with bioactive molecules. Started in 2016, the IMODE project is funded by the European Interreg 2 Seas programme and co-financed by the European Regional Development Fund (ERDF).
The project’s overall objective is to bring together the specific transdisciplinary skills and experiences of partners (academic research groups, development agencies, SMEs) in order to provide the 2 Seas Area with strategic advantages for innovative pharmaceutical and medical applications. The IMODE project is motivated by an unmet need to develop solutions to addressing societal challenges to improve healthcare and provide novel and effective medication for various cardiovascular or gastro-intestinal conditions that lack or have inadequate treatment, all while keeping medical costs low.
More information about IMODE: project-imode.eu